enGene Therapeutics Inc. (ENGNW) Operating income 2022–2025
enGene Therapeutics Inc. (ENGNW) annual operating income history from SEC filings — each fiscal year as reported.
-$123.2MFY2025 · since FY2022: -$19.4M → -$123.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$123.2M | -97.7% |
| FY2024 | -$62.3M | -139.1% |
| FY2023 | -$26.1M | -34.1% |
| FY2022 | -$19.4M | — |
Source: SEC XBRL filings · For reference only · Not investment advice